Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

DiagnaMed Holdings Corp DGNMF


Primary Symbol: C.DMED

DiagnaMed Holdings Corp. is a Canada-based generative artificial intelligence healthcare company. The Company is focused on developing and commercializing CERVAI, a proprietary brain health artificial intelligence (AI) platform. CERVAI leverages generative AI that predicts and monitors brain age and provides actionable insights and tools to diagnose, prevent or improve cognitive decline for mental health and neurodegenerative disorders. The Company is developing and commercializing a suite of generative AI solutions powered by OpenAI's ChatGPT to support the healthcare market in improving patient outcomes, operational workflow and efficiency. AI Medical Chatbot is a personal medical chatbot designed to give people a way to obtain fast and personalized medical information based on a person’s unique medical condition.


CSE:DMED - Post by User

Post by Betteryear2on Mar 20, 2024 10:01am
33 Views
Post# 35942604

DiagnaMed BRAIN AGE® Trademark Registration Approved

DiagnaMed BRAIN AGE® Trademark Registration ApprovedTORONTO, March 20, 2024 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. (“DiagnaMed” or the “Company”) (CSE: DMED) (OTCQB: DGNMF), an artificial intelligence digital healthcare company, announced its application for registration for trademark on its BRAIN AGE® brand has been approved by the Canadian Intellectual Property Office (CIPO), particularly for commercial use throughout Canada for the goods and services for which it is registered as a neurological monitoring apparatus, electroencephalogram-based apparatus, and brain monitoring apparatus.

DiagnaMed Announces BRAIN AGE® Trademark Registration (globenewswire.com)
<< Previous
Bullboard Posts